Spruce Biosciences Inc.

NASDAQ: SPRB · Real-Time Price · USD
8.75
-0.55 (-5.93%)
At close: Jun 09, 2025, 3:57 PM
8.75
0.00%
After-hours: Aug 13, 2025, 08:00 PM EDT

Spruce Biosciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
2.91M 4.91M 7.1M 9.57M 10.13M 10.09M 7.2M 4.13M 1.96M n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a 16K 33K 107K 184K 297K 387K 9.37M 9.4M 9.36M 9.35M 382K 369K 281K 185K 90K
Gross Profit
2.91M 4.91M 7.08M 9.54M 10.02M 9.9M 6.91M 3.74M -7.41M -9.4M -9.36M -9.35M -382K -369K -281K -185K -90K
Operating Income
-58.01M -56.15M -43.24M -47.49M -51.43M -51.99M -52.94M -50.84M -48.75M -47.28M -44.31M -44.15M -43.98M -42.07M -41.27M -39.42M -34.1M
Interest Income
2.8M 3.42M 4.17M 4.79M 5.12M 4.56M 4.33M 3.17M 2M 1.52M 428K 203K 99K 41K 41K n/a n/a
Pretax Income
-55.45M -53.04M -39.43M -43.11M -46.75M -47.92M -49.11M -48.16M -47.21M -46.18M -44.22M -44.27M -44.17M -42.29M -41.45M -39.59M -34.26M
Net Income
-55.45M -53.04M -39.43M -43.11M -46.75M -47.92M -48.17M -47.06M -46.1M -45.1M -44.09M -44.29M -44.2M -42.29M -41.45M -39.59M -34.26M
Selling & General & Admin
13.98M 14.64M 14.28M 14.06M 13.52M 12.65M 12.97M 12.5M 12.31M 12.08M 11.69M 11.72M 11.49M 11.37M 11.01M 10.01M 8.14M
Research & Development
46.94M 46.42M 36.06M 43M 48.04M 49.43M 47.17M 42.47M 38.4M 35.2M 32.62M 32.43M 32.49M 30.7M 30.25M 29.41M 25.96M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a 104K 162K 201K 242K 158K 119K 155K 165K 180K
Operating Expenses
60.92M 61.06M 50.34M 57.06M 61.55M 62.08M 60.14M 54.97M 50.71M 47.28M 44.31M 44.15M 43.98M 42.07M 41.27M 39.42M 34.1M
Interest Expense
246K 307K 357K 405K 449K 483K 506K 497K 464K 420K 379K 357K 343K 345K 335K 326K 338K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
60.92M 61.06M 50.34M 57.06M 61.55M 62.08M 60.14M 54.97M 50.71M 47.28M 44.31M 44.15M 43.98M 42.07M 41.27M 39.42M 34.1M
Income Tax Expense
n/a n/a n/a -17K -17K -17K -964K -1.1M -1.1M -1.07M -127K 29K 129K 100K 100K 100K n/a
Shares Outstanding (Basic)
571.28K 536.44K 536.93K 535.12K 534.25K 533.39K 529.24K 527.12K 414.7K 612.64K 612.57K 610.83K 610.8K 609.8K 607.55K 606.57K 605.38K
Shares Outstanding (Diluted)
571.28K 536.44K 536.93K 535.12K 534.25K 533.39K 529.24K 527.12K 414.7K 612.64K 612.57K 610.83K 610.8K 609.8K 607.55K 606.57K 605.38K
EPS (Basic)
-99 -96 -71.25 -78 -85.5 -93.75 -92.25 -87.75 -82.5 -72 -70.5 -70.5 -70.5 -67.5 -66 -63.75 -56.25
EPS (Diluted)
-99 -96 -71.25 -78 -85.5 -93.75 -92.25 -87.75 -82.5 -72 -70.5 -70.5 -70.5 -67.5 -66 -63.75 -56.25
EBITDA
-55.17M -52.68M -39.02M -42.65M -46.18M -47.25M -48.31M -47.28M -46.34M -45.33M -43.45M -43.53M -43.44M -41.58M -40.78M -39.02M -33.75M
EBIT
-55.21M -52.73M -39.07M -42.7M -46.3M -47.44M -48.61M -47.66M -46.74M -45.76M -43.84M -43.91M -43.82M -41.95M -41.11M -39.26M -33.92M
Depreciation & Amortization
37K 46K 53K 60K 122K 184K 297K 387K 403K 429K 388K 377K 382K 369K 291K 203K 125K